These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28701995)

  • 1. Cerebellar Dysfunction in Multiple Sclerosis.
    Wilkins A
    Front Neurol; 2017; 8():312. PubMed ID: 28701995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tremor in multiple sclerosis: The intriguing role of the cerebellum.
    Ayache SS; Chalah MA; Al-Ani T; Farhat WH; Zouari HG; Créange A; Lefaucheur JP
    J Neurol Sci; 2015 Nov; 358(1-2):351-6. PubMed ID: 26421829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the cerebellum in multiple sclerosis.
    Weier K; Banwell B; Cerasa A; Collins DL; Dogonowski AM; Lassmann H; Quattrone A; Sahraian MA; Siebner HR; Sprenger T
    Cerebellum; 2015 Jun; 14(3):364-74. PubMed ID: 25578034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis and the cerebellum.
    Tornes L; Conway B; Sheremata W
    Neurol Clin; 2014 Nov; 32(4):957-77. PubMed ID: 25439291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical manifestations of cerebellar disease.
    Javalkar V; Khan M; Davis DE
    Neurol Clin; 2014 Nov; 32(4):871-9. PubMed ID: 25439285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential tremor and the cerebellum.
    Louis ED
    Handb Clin Neurol; 2018; 155():245-258. PubMed ID: 29891062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebellar dysfunction in multiple sclerosis: evidence for an acquired channelopathy.
    Waxman SG
    Prog Brain Res; 2005; 148():353-65. PubMed ID: 15661203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for early, non-lesional cerebellar damage in patients with multiple sclerosis: DTI measures correlate with disability, atrophy, and disease duration.
    Deppe M; Tabelow K; Krämer J; Tenberge JG; Schiffler P; Bittner S; Schwindt W; Zipp F; Wiendl H; Meuth SG
    Mult Scler; 2016 Jan; 22(1):73-84. PubMed ID: 25921041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switch in the expression of mGlu1 and mGlu5 metabotropic glutamate receptors in the cerebellum of mice developing experimental autoimmune encephalomyelitis and in autoptic cerebellar samples from patients with multiple sclerosis.
    Fazio F; Notartomaso S; Aronica E; Storto M; Battaglia G; Vieira E; Gatti S; Bruno V; Biagioni F; Gradini R; Nicoletti F; Di Marco R
    Neuropharmacology; 2008 Sep; 55(4):491-9. PubMed ID: 18619983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebellar Assessment in Early Multiple Sclerosis.
    Moroso A; Ruet A; Deloire M; Lamargue-Hamel D; Cubizolle S; Charré-Morin J; Saubusse A; Brochet B
    Cerebellum; 2017 Apr; 16(2):607-611. PubMed ID: 27815857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuropathology of the adult cerebellum.
    Koeppen AH
    Handb Clin Neurol; 2018; 154():129-149. PubMed ID: 29903436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered synaptic and firing properties of cerebellar Purkinje cells in a mouse model of ARSACS.
    Ady V; Toscano-Márquez B; Nath M; Chang PK; Hui J; Cook A; Charron F; Larivière R; Brais B; McKinney RA; Watt AJ
    J Physiol; 2018 Sep; 596(17):4253-4267. PubMed ID: 29928778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent motor dysfunction despite homeostatic rescue of cerebellar morphogenesis in the Car8 waddles mutant mouse.
    Miterko LN; White JJ; Lin T; Brown AM; O'Donovan KJ; Sillitoe RV
    Neural Dev; 2019 Mar; 14(1):6. PubMed ID: 30867000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of cerebellar ataxia and tremor in multiple sclerosis with topiramate: a case report.
    Schroeder A; Linker RA; Lukas C; Kraus PH; Gold R
    Clin Neuropharmacol; 2010; 33(6):317-8. PubMed ID: 21079458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A channelopathy contributes to cerebellar dysfunction in a model of multiple sclerosis.
    Shields SD; Cheng X; Gasser A; Saab CY; Tyrrell L; Eastman EM; Iwata M; Zwinger PJ; Black JA; Dib-Hajj SD; Waxman SG
    Ann Neurol; 2012 Feb; 71(2):186-94. PubMed ID: 22367990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding tremor in multiple sclerosis: prevalence, pathological anatomy, and pharmacological and surgical approaches to treatment.
    Labiano-Fontcuberta A; Benito-León J
    Tremor Other Hyperkinet Mov (N Y); 2012; 2():. PubMed ID: 23439953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organotypic cultures of cerebellar slices as a model to investigate demyelinating disorders.
    Doussau F; Dupont JL; Neel D; Schneider A; Poulain B; Bossu JL
    Expert Opin Drug Discov; 2017 Oct; 12(10):1011-1022. PubMed ID: 28712329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical symptoms of cerebellar dysfunction and their topodiagnostical significance.
    Dichgans J
    Hum Neurobiol; 1984; 2(4):269-79. PubMed ID: 6715211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ataxia, dysmetria, tremor. Cerebellar diseases.
    Kornegay JN
    Probl Vet Med; 1991 Sep; 3(3):409-16. PubMed ID: 1802262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-type plasminogen activator is an extracellular mediator of Purkinje cell damage and altered gait.
    Cops EJ; Sashindranath M; Daglas M; Short KM; da Fonseca Pereira C; Pang TY; Lijnen RH; Smyth IM; Hannan AJ; Samson AL; Medcalf RL
    Exp Neurol; 2013 Nov; 249():8-19. PubMed ID: 23939410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.